Microglia Medium (MM) is a complete medium designed for optimal growth of normal human brain-derived microglia in vitro. It is a sterile, liquid medium which contains essential and non-essential amino acids, vitamins, organic and inorganic compounds, hormones, growth factors, trace minerals and a low concentration of fetal bovine serum (5%). The medium is bicarbonate buffered and has a pH of 7.4 when equilibrated in an incubator with an atmosphere of 5% CO2/95% air. The medium is formulated (quantitatively and qualitatively) to provide a defined and optimally balanced nutritional environment that selectively promotes growth of normal human microglia in vitro.
Components
MM consists of 500 ml of basal medium, 25 ml of fetal bovine serum (FBS, Cat. No. 0025), 5 ml of microglia growth supplement (MGS, Cat. No. 1952) and 5 ml of penicillin/streptomycin solution (P/S, Cat. No. 0503).
Product Use
MM is for research use only. It is not approved for human or animal use, or for application in in vitro diagnostic procedures.
Storage
Store the basal medium at 4°C, the MGS, the FBS and the P/S solution at -20°C. Protect from light.
Shipping
Gel ice.
复蒙基因|FMGBio(www.sciencellonline.com或www.zqxzbio.com )成立于2005年,专长于为生物医药领域的医疗机构、研究中心、企业、临床医生等提供课题设计、基金联合申请、实验技术服务、论文相关服务、采购外包等整体服务,目前已经成长为国内领先的转化医学外包品牌。
复蒙基因|FMGBio的产品线比较丰富:现有美国Sciencell(原代细胞及配套全能培养基及无血清培养基)、3D Bioteck(三维细胞培养及转染试剂)、年产1000万毫升的内蒙古牛血清生产基地等。
复蒙基因|FMGBio的PI团队已经发展到专职PI 20人,联席PI 312人,其中大多数拥有海外背景。截止到2009年3月,以PI或联席PI为第一作者发表SCI 论文1682 篇(总IF 值为5721.82,其中影响因子IF>5.0 的论文216 篇,IF>10.0论文32 篇)。
蒙基因|FMGBio倡导的转化医学“B-B-B”模式:“与临床一线的医生合作,共同探讨医学在临床诊断、治疗、预防、流行病学研究中的经验和问题,从中挖掘整理、形成针对临床一线需求的研究命题(Bedside);在实验室对这些命题进行分子水平、细胞水平和整体水平的系统生物学研究,探讨发病与转归机制、寻找药物靶标、诊断标志物,发表高水平研究论文和申报专利,研发新的诊断产品、药品、医疗器械和诊断治疗方案(Bench);并进一步在临床上进行临床试用,最终进行项目融资、产业化转化和产品的生产销售,面向临床一线进行推广,造福于病人(Bedside)。
电话:021-51262076 13371892488
Email:wwwfudan@163.com QQ:739782475
网址:www.zqxzbio.com